[Favorable response to cyclosporin A in a patient with steroid resistant autoimmune haemolytic anaemia].
We present a patient with isolated steroid resistant autoimmune haemolytic anaemia successfully treated with cyclosporin A for 7 months with no adverse side effects and free of disease after 2 years of therapy. We thus recommend to consider cyclosporin A as a first choice in steroid resistant patients with autoimmune haemolytic anaemia. More studies are necessary to assess the efficacy and safety of this treatment.
Baratta
Luigi
L
Dipartimento di Medicina Clinica, Università La Sapienza, Roma.
Golluscio
Vincenzina
V
Delfino
Massimo
M
D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy*; D016572:Cyclosporine / Q000627:therapeutic use*; D004351:Drug Resistance; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D012074:Remission Induction
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011241:Prednisone